Clinical Trial Update: SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial [Phase 1]

View source ↗

Summary

This entry describes an ongoing Phase 1 trial (SUNSET) evaluating SBRT for ultra-central non-small cell lung cancer, with status active but not recruiting. No e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING